21 – 30 of 205
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Platelet mitochondrial DNA methylation : A novel biomarker for myocardial infarction – A preliminary study
2023) In International Journal of Cardiology(
- Contribution to journal › Article
-
Mark
Plasma Protein Profiling of Incident Cardiovascular Diseases : A Multisample Evaluation
(
- Contribution to journal › Article
-
Mark
Cardiovascular magnetic resonance derived pressure volume loop variables in patients with ST-elevation myocardial infarction provide physiological information beyond ejection fraction
2023) 5th Nordic Cardiac Imaging Meeting(
- Contribution to conference › Poster
-
Mark
Cardiovascular magnetic resonance derived pressure volume loop variables in patients with ST-elevation myocardial infarction provide physiological information beyond ejection fraction
2023) Svenska kardiovaskulära vårmötet(
- Contribution to conference › Poster
-
Mark
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019 : a registry-based cohort study
(
- Contribution to journal › Article
-
Mark
Bivalirudin Versus Heparin During PCI in NSTEMI : Individual Patient Data Meta-Analysis of Large Randomized Trials
(
- Contribution to journal › Article
- 2022
-
Mark
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
(
- Contribution to journal › Article
-
Mark
Role of smooth muscle YAP and TAZ in protection against phenotypic modulation, inflammation, and aneurysm development
(
- Contribution to journal › Scientific review
-
Mark
Long-term prognosis after a first myocardial infarction : eight years follow up of the case-control study PAROKRANK
(
- Contribution to journal › Article